Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/11/931
Active ingredient: Plerixafor
Indication: Adjunctive treatment to cytotoxic therapy in acute myeloid leukaemia
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Orphan designation EMA/OD/074/11 (2011)9417 of 09/12/2011
18/09/2014 Removal of orphan designation from Community Register